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Abstract
Hepatic solitary fibrous tumor (SFT) is a rare tumor originating from the mesenchyme. Here we report a new case
of SFT in the liver and review the clinical presentation, radiological and operative findings, diagnosis, treatment,
and outcome. The patient was a 59-year-old man who presented with progressive fatigue for 3 months and an
abdominal mass for 3 days. On laboratory tests, no abnormality was detected except that abdominal
ultrasonography revealed a 9.0 × 6.2 cm hypoechogenic mass in the left lobe of the liver. A computed
tomographic scan confirmed a hypodense lesion in the left lobe of the liver. The patient underwent left
hepatectomy. SFT was diagnosed on the basis of histopathological findings. The patient was free from all
symptoms and had no signs of local recurrence after 24 months’ follow up.
Background
Solitary fibrous tumor (SFT) is a rare spindle-cell neo-
plasm of mesenchymal origin, first described by Klem-
perer and Robin in the visceral pleura in 1931 [1]. It
u s u a l l yi sf o u n di nt h et h o r a c i cc a v i t ya n dp l e u r a ,b u t ,
rarely, it can involve other organs such as the mediasti-
num [2], the skin [3], soft tissue [4], the thyroid gland
[5], the orbit [6], and others. Although most solitary
fibrous tumors have benign behavior, some may have
malignant features such as metastasis and recurrence.
Clinical or radiological findings are not specific and can-
not exclude malignancy. Preoperative cytology may be
inconclusive or misleading. Currently, the prevailing
view is that immunohistology, including CD34 and
vimentin, should be used to precisely diagnose SFT [7].
The outcome of an SFT of the liver is mostly related to
resectability [8]. Thus, complete surgical removal of the
neoplasm is most commonly proposed. We report a
case of SFT of the liver and review the literature to date.
Case Presentation
A 59-year-old man was admitted to our hospital because
of progressive fatigue for 3 months and an abdominal
mass for 3 days. The patient had no history of viral
hepatitis. Laboratory tests, including routine biochemis-
try, liver function, and tumor markers, were normal.
A plain chest X-ray was normal. Abdominal ultrasono-
graphy revealed a 9.0 × 6.2 cm hypoechogenic mass in
the left lobe of the liver. Computed tomography (CT)
demonstrated a large heterogeneous circumscribed mass
in the left hepatic lobe and contrast enhancement in the
arterial and portal phases (Figure 1A, B, C). Left hepa-
tectomy was performed, and the patient recovered with-
out complications.
Grossly, the tumor was a large, gray-white, lobulated,
well-circumscribed partially encapsulated mass, measur-
ing 9 × 7 × 6 cm. In the peripheral liver parenchyma,
the vascular structure and bile duct were compressed,
and no cirrhosis or fibrosis was observed (Figure 1C).
Histologically, the tumor was composed principally of
spindle cells arranged in short, ill-defined fascicles in
some zones and randomly in others (Figure 2A, B).
They were intermingled with striking areas of hyaliniza-
tion. The vascular pattern varied from narrow vascular
clefts to gaping, branching vascular channels. Cystic
degeneration was present. Little mitotic activity was
observed (fewer than 1-2 mitoses in 10 high-power
fields (HPF)), and these foci showed more dense cellu-
larity and more nuclear atypia; this was considered to
represent low-grade malignant transformation. This
tumor also showed irregular infiltration of the peripheral
liver (Figure 2A). Little inflammatory cell infiltration
without necrosis was seen.
Immunohistochemically, the tumor cells were strongly
positive for CD34 (Figure 2C), CD99 (Figure 2D), Bcl-2,
and vimentin and negative for smooth muscle actin
(SMA), CD31, cytokeratin, S-100, CD117, and epithelial
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the liver was diagnosed pathologically. The patient was
free from any symptoms and without local recurrence
for 24 months.
Discussion
Primary solitary fibrous tumor of the liver is an extre-
mely rare neoplasm. Individual case reports are infre-
quent. The first description of this type of tumor
involving the liver may be that provided by Nevius and
Friedman in 1959 [9]. A review of the literature revealed
fewer than 40 reported SFTs of the liver to date [7,8,10].
These tumors mainly occurred in women, at a ratio of
71.7 percent female to 28.3 percent male. The mean age
w a s5 8 . 9y e a r so l d .T h et u m o rc a nb ef o u n di ne i t h e r
the right or the left hepatic lobe. Clinically, most
patients may be asymptomatic, whereas other patients
are symptomatic with abdominal pain, abdominal full-
ness and mass, weight loss, and fatigue when the tumor
grows. Some present with alterations of liver tests and
compression of biliary ducts leading to cholestasis [11].
In general, the clinical presentation of patients with SFT
usually is mild and not distinctive from that of other
lesions of the liver.
The radiological findings may suggest the diagnosis of
SFT, but benign or malignant hepatic tumors such as
hepatocellular carcinoma, sarcoma, leiomyoma, and
inflammatory pseudotumor may have similar features
[11]. Thus, the radiological findings are nonspecific and
cannot distinguish between benign and malignant
tumors. Therefore, in the present case, the diagnosis of
SFT of the liver was based on the association of typical
histological and immunohistochemical features. CD34
positivity distinguishes SFT from other spindle-cell
tumors [12], and it is necessary to combine other mar-
kers for differential diagno s i s .I no u rc a s e ,t h et u m o r
cells were strongly positive for CD34, CD99, Bcl-2, and
vimentin and negative for smooth muscle actin (SMA),
CD31, cytokeratin, S-100, CD117, and epithelial mem-
brane antigen (EMA).
T h ep a t h o l o g i cf e a t u r e so ft h eS F To ft h el i v e r
described here resemble those described for solitary
f i b r o u st u m o r so fo t h e rl o cations [13]. Typical SFTs
show a patternless architecture characterized by a com-
bination of alternating hypocellular and hypercellular
areas separated from each other by thick bands of hyali-
nized, somewhat keloidal collagen and branching
haemangiopericytoma-like vessels. These features differ-
entiate SFTs from other liver mesenchymal tumors.
Immunohistochemically, SFTs consistently express
CD34, are variably positive for CD99 and Bcl-2, and
lack cytokeratin or other mesothelial markers. The pre-
sence of mitotic figures is associated with but not pre-
dictive of aggressive clinical behavior [14]. The
histologic features of this malignancy include high cellu-
larity and mitotic activity, pleomorphism, necrosis, and
local invasion [8].
The differential diagnosis includes leiomyoma (con-
sists of intersecting bundles of smooth muscle cells;
SMA positive, CD34 negative) [15], inflammatory pseu-
dotumor (consists of myofibroblasts, fibroblast cells
mixed with inflammatory cells, predominantly plasma
cells, lymphocytes, as well as eosinophils; SMA positive,
Figure 1 Single mass in the left hepatic lobe.( A )C Ts c a n
demonstrated a mass (9.0 × 6.2cm) in left hepatic lobe. (B) and (C)
Contrast enhancement in arterial and portal phases was found in
the mass. (D) Grossly, a large, gray-white, lobulated, well-
circumscribed, partially encapsulated mass was removed after
hepatoectomy.
Figure 2 Histological section of the SFT.( A )a n d( B )T h et u m o r
was composed principally of spindle cells arranged in short, ill-
defined fascicles in some zones and randomly in others (A; H & E
10×; B; 40×). Immunohistochemically, the tumor cells were strongly
positive for CD34 (C; 20×) and CD99 (D; 20×).
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coma (forms a “herringbone” pattern; CD34 negative),
and stromal tumor (CD117 and CD34 positive) [11].
Although most cases have benign clinical behavior, there
is no strict correlation between histological findings and
biological behavior. Some may have malignant histological
features and recur locally or metastasize [17]. Therefore, a
complete surgical resection is the first choice for treatment
and is curative in most cases. Follow-up surveillance is
necessary. According to the limited literature on hepatic
SFTs, all but three patients underwent surgical resection.
There is only one report of distant metastasis to the bone,
and it was successfully treated with chemotherapy [17].
Among 92 cases of extrathoracic SFT, ten cases with aty-
pical features including high cellularity, >4 mitoses/10
HPF, nuclear pleomorphism, and necrosis were associated
with aggressive clinical behavior. Among these ten
patients, eight had local recurrence or distant metastases
[14]. Interestingly, one widely metastatic tumor did not
have any atypical features in the primary lesion but
acquired four such features in the metastatic foci. These
findings confirm that the behavior of extrathoracic SFTs is
unpredictable. Due to the rarity of this tumor, the prog-
nosis has not been well defined [8]. Therefore, patients
with SFTs in any location require careful long-term follow
up, and it is probably unwise to regard any such lesion as
definitely benign [14].
Conclusion
We observed a rare case of SFT of the liver. Correct
interpretation of unique pathological findings and CD34
immunoreactivity plays a significant role in differentiat-
ing SFT from other spindle-cell neoplasms of the liver.
A complete surgical resection is the treatment of choice
and is curative in most cases, and follow-up surveillance
is necessary. The outcome of SFTs is mostly related to
resectability rather than pathologic grade or tumor size.
Given the limited number of cases reported in the litera-
ture, it is still difficult to establish the long-term prog-
nosis of this disease.
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